AVANOS MEDICAL INC (AVNS) Stock Price, Quote, News and Overview
NYSE:AVNS - New York Stock Exchange, Inc. - US05350V1061 - Common Stock - Currency: USD
AVNS Quote, Performance and Key Statistics
12.53
+0.1 (+0.8%)
The current stock price of AVNS is 12.53 USD. In the past month the price decreased by -11.51%. In the past year, price decreased by -30.77%.
AVNS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 31.04 | 47.31B | ||
| COO | COOPER COS INC/THE | 21.9 | 16.51B | ||
| ALGN | ALIGN TECHNOLOGY INC | 19.73 | 13.49B | ||
| SOLV | SOLVENTUM CORP | 10.09 | 11.68B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.29 | 7.10B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 27.2 | 5.59B | ||
| BLCO | BAUSCH + LOMB CORP | 22.4 | 4.91B | ||
| ICUI | ICU MEDICAL INC | 22.05 | 3.38B | ||
| HAE | HAEMONETICS CORP/MASS | 14.64 | 3.11B | ||
| XRAY | DENTSPLY SIRONA INC | 8.21 | 2.73B | ||
| UFPT | UFP TECHNOLOGIES INC | 27.22 | 1.59B | ||
| NEOG | NEOGEN CORP | 13.68 | 1.13B |
Related stock screener links
About AVNS
Company Profile
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The firm offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The firm conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The firm's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Company Info
AVANOS MEDICAL INC
5405 Windward Parkway, Suite 100 South
Alpharetta GEORGIA 30004 US
CEO: Joseph F. Woody
Employees: 3771
Company Website: https://avanos.com/
Investor Relations: https://avanos.investorroom.com
Phone: 18444282667
AVANOS MEDICAL INC / AVNS FAQ
What is the stock price of AVANOS MEDICAL INC today?
The current stock price of AVNS is 12.53 USD. The price increased by 0.8% in the last trading session.
What is the ticker symbol for AVANOS MEDICAL INC stock?
The exchange symbol of AVANOS MEDICAL INC is AVNS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is AVNS stock listed?
AVNS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for AVANOS MEDICAL INC stock?
7 analysts have analysed AVNS and the average price target is 17.34 USD. This implies a price increase of 38.39% is expected in the next year compared to the current price of 12.53. Check the AVANOS MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AVANOS MEDICAL INC worth?
AVANOS MEDICAL INC (AVNS) has a market capitalization of 576.38M USD. This makes AVNS a Small Cap stock.
How many employees does AVANOS MEDICAL INC have?
AVANOS MEDICAL INC (AVNS) currently has 3771 employees.
What are the support and resistance levels for AVANOS MEDICAL INC (AVNS) stock?
AVANOS MEDICAL INC (AVNS) has a resistance level at 12.54. Check the full technical report for a detailed analysis of AVNS support and resistance levels.
Is AVANOS MEDICAL INC (AVNS) expected to grow?
The Revenue of AVANOS MEDICAL INC (AVNS) is expected to decline by -1.74% in the next year. Check the estimates tab for more information on the AVNS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AVANOS MEDICAL INC (AVNS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AVNS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AVNS, evaluating the profitability, health, valuation and growth aspects
- AVANOS MEDICAL INC (AVNS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AVANOS MEDICAL INC (AVNS) Sales and EPS estimates to see what analysts future expectations are.
- AVANOS MEDICAL INC (AVNS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AVANOS MEDICAL INC (AVNS) Insider and Institutional Ownership to learn about the owners and their transactions.
- AVANOS MEDICAL INC (AVNS) Stock Chart to make your own analysis
- AVANOS MEDICAL INC (AVNS) Latest news and press-releases to stay up to date.
Does AVANOS MEDICAL INC (AVNS) stock pay dividends?
AVNS does not pay a dividend.
When does AVANOS MEDICAL INC (AVNS) report earnings?
AVANOS MEDICAL INC (AVNS) will report earnings on 2025-04-30, before the market open.
What is the Price/Earnings (PE) ratio of AVANOS MEDICAL INC (AVNS)?
The PE ratio for AVANOS MEDICAL INC (AVNS) is 9.94. This is based on the reported non-GAAP earnings per share of 1.26 and the current share price of 12.53 USD. Check the full fundamental report for a full analysis of the valuation metrics for AVNS.
What is the Short Interest ratio of AVANOS MEDICAL INC (AVNS) stock?
The outstanding short interest for AVANOS MEDICAL INC (AVNS) is 1.99% of its float. Check the ownership tab for more information on the AVNS short interest.
AVNS Technical Analysis
AVNS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AVNS. AVNS has an average financial health and profitability rating.
AVNS Financial Highlights
Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 1.26. The EPS decreased by -8.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.97% | ||
| ROE | -47.33% | ||
| Debt/Equity | 0.15 |
AVNS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to AVNS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -8.93% and a revenue growth -1.74% for AVNS